Flora Matrix Vaginal & UTI

8 billion CFU of Lactobacillus acidophilus La-14 and 2 billion CFU of Lactic acid bacillus rhamnosus HN001 per capsule, with an additional 200 mg of Vaccinium macrocarpon extract in a 50:1 extract (10 gram dried herb equivalent). Designed to promote favorable vaginal flora, reduce the risk and improve treatment outcomes for bacterial vaginosis, urinary tract infections, and vulvovaginal candidiasis. Each package provides 40 shelf-stable servings without the need for refrigeration. When considering the role of bacteria in the human body, the digestive tract immediately comes to mind. Yet, there are other areas of the body that require a delicate balance of microbes, such as the skin, lungs, and genitourinary tract. The vagina contains its own unique microbiome with a plethora of lactobacillus species to secrete lactic acid and promote an acidic environment. This environment Prevents the growth of unwanted bacteria, yeast, and other microorganisms, reducing the risk of infections and inflammatory conditions. Some of the most common concerns regarding an imbalance of bacteria in the vagina are urinary tract infections (UTIs), bacterial vaginosis (BV), and vulvovaginal candidiasis (VVC). While each condition is distinct and unique, they can have overlapping signs and symptoms such as vaginal discharge, itching, burning, and pain (either with urination or intercourse). Each of these conditions can be chronic and recurrent. Most importantly, all 3 conditions can negatively impact quality of life, and effective alternatives to antibiotic therapy are in high demand. While the role of probiotics is well established for gastrointestinal tract health, we are more recently realizing the health benefits and excellent safety record in the field of vaginal health. Several studies have now been completed to show that the complementary use of probiotics with antibiotics can improve BV symptoms (such as odor and discharge), vaginal pH, and BV eradication success rates. In addition, probiotic therapy demonstrated a significantly higher rate of normalized vaginal microbiota compared to controls receiving only antibiotics for BV treatment. Similarly, a plethora of in vitro data and animal studies suggest that targeted probiotic strains are effective in preventing the growth of Candida albicans and, consequently, the incidence and recurrence of VVC. A particular mixture of Lactobacillus acidophilus La-14 and Lacticaseibacillus rhamnosus HN001 was studied in combination with lactoferrin in women with abnormal vaginal microbiota. After 15 days, the results showed that oral intake of lactobacilli and lactoferrin resulted in significant vaginal colonization, restoration of the nugent score (a measure of bacterial balance), and improvement in symptoms of vaginal itching and discharge. A separate study examined this same probiotic and lactoferrin blend in 48 women with vulvovaginal candidiasis (VVC). These results showed that after 3 months, vaginal discharge and itching were significantly improved and the recurrence rate was significantly reduced in participants taking the probiotic-lactoferrin combination compared to placebo. These effects lasted for at least 6 months after the initial intervention. Regarding non-probiotic natural agents, cranberry extract has traditionally been used for the prevention and treatment of uncomplicated urinary tract infections. Cranberry juice contains tannins known as proanthocyanidins and was traditionally thought to acidify urine and thus reduce bacterial growth in the bladder. However, cranberry extract specifically prevents the adhesion of bacteria to the bladder wall. Clinical trials of cranberry juice and extracts Standardized studies have revealed a decreased need for antibiotics, lower recurrence and incidence of UTIs, and fewer bacteria in the urine. Flora-Matrix Vaginal and UTI provides 8 billion CFU of Lactobacillus acidophilus La-14, 2 billion CFU of Lacticaseibacillus rhamnosus HN001, and 200 mg of cranberry extract in a potent 50:1 extract (based on a 10-gram dried herb equivalent) per capsule. Collectively, Flora-Matrix Vaginal and UTI is designed to promote favorable vaginal flora, reduce the risk of BV, UTI, and VVC, and improve treatment outcomes. Available in blister packs containing 40 vegetarian capsules per pack. Flora-Matrix Vaginal and UTI is shelf-stable and free of gluten and soy. Flora-Matrix Vaginal and UTI belongs to the Flora-Matrix family of probiotics, each containing specialized strains for targeted results. Each Flora-Matrix probiotic contains unique strains with distinct activity and health benefits. These strains are individually selected and thoroughly studied at validated dosages, ensuring targeted clinical results without the need for excessive numbers of colony-forming units.